ZANGANEH MAHKAM purchased 0.1% of their position (338.39K shares) of SUMMIT THERAPEUTICS INC. on the open market
Open‑market purchase worth $5.98M — a small addition. The strongest form of insider conviction signal.
P · 2 purchases
Filed: 9/11/2025ACC: 0001599298-25-000143
+338.39K
Net shares
Net buyer
$5.98M
Total acquired
2
Open market trades
2B · 0S
2
Total transactions
338.39K acquired
Non-Derivative Transactions2
Common Stock
Indirect
Shares
+333.39K
Price / share
$17.68
Trade value
$5.89M
% of position
0.1%
9/10/2025
555.75M→556.09M
Common Stock
Indirect
Shares
+5K
Price / share
$18.07
Trade value
$90.35K
% of position
0.0%
9/11/2025
556.09M→556.09M
Total
Net shares
+338.39K
Net value
$5.98M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 9/10/2025 | P · Purchase | +333.39K | $17.68 | $5.89M | 0.1% | 555.75M | 556.09M |
| Common Stock Indirect | 9/11/2025 | P · Purchase | +5K | $18.07 | $90.35K | 0.0% | 556.09M | 556.09M |
| Total | +338.39K | $5.98M | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)4
Common Stock
IndirectShares owned50K
Common Stock
IndirectShares owned25.46M
Common Stock
IndirectShares owned10.20M
Common Stock
DirectShares owned31K
Total
31K direct·35.71M indirect35.74M
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 50K | Indirect |
| Common Stock | 25.46M | Indirect |
| Common Stock | 10.20M | Indirect |
| Common Stock | 31K | Direct |
| Total | 35.74M | 31K direct·35.71M indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported